<SEC-DOCUMENT>0000950170-24-067324-index.html : 20240531
<SEC-HEADER>0000950170-24-067324.hdr.sgml : 20240531
<ACCEPTANCE-DATETIME>20240531161505
ACCESSION NUMBER:		0000950170-24-067324
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240530
FILED AS OF DATE:		20240531
DATE AS OF CHANGE:		20240531

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Greene John
		CENTRAL INDEX KEY:			0001610732
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		241009863

	MAIL ADDRESS:	
		STREET 1:		51 LIME STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			EC3M 7DQ

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>